XML 19 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jul. 31, 2023
Apr. 30, 2023
Current Assets:    
Cash and cash equivalents $ 12,699 $ 8,078
Restricted cash 8,869 5,737
Receivables, less allowance; $560; $476, on each respective date 42,461 46,081
Inventories 22,126 21,889
Prepaid expenses and other current assets 7,365 6,135
Total Current Assets 93,520 87,920
Property, plant and equipment, at cost 63,023 61,368
Accumulated depreciation (45,684) (44,966)
Net Property, Plant and Equipment 17,339 16,402
Right of use assets 8,612 9,170
Other assets 5,347 5,406
Total Assets 124,818 118,898
Current Liabilities:    
Short-term borrowings 5,054 3,587
Current portion of financing liability 659 642
Current portion of financing lease liabilities 86 85
Current portion of operating lease liabilities 1,912 1,967
Accounts payable 22,140 23,599
Employee compensation and amounts withheld 4,903 4,304
Deferred revenue 7,067 4,097
Other accrued expenses 2,408 1,772
Total Current Liabilities 44,229 40,053
Long-term portion of financing liability 27,958 28,132
Long-term portion of financing lease liabilities 143 148
Long-term portion of operating lease liabilities 6,645 7,136
Accrued pension and deferred compensation costs 3,861 3,546
Deferred income taxes 989 943
Other non-current liabilities 453 455
Total Liabilities 84,278 80,413
Commitments and Contingencies
Stockholders' Equity:    
Common stock, $2.50 par value, Authorized – 5,000 shares; Issued – 2,907 shares; 2,833 shares; – Outstanding – 2,904 shares; 2,830 shares, on each respective date 7,269 7,084
Additional paid-in-capital 4,565 5,059
Retained earnings 31,235 28,761
Accumulated other comprehensive loss (3,586) (3,442)
Common stock in treasury, at cost, 3 shares, on each respective date (53) (53)
Total Kewaunee Scientific Corporation Stockholders' Equity 39,430 37,409
Non-controlling interest 1,110 1,076
Total Stockholders' Equity 40,540 38,485
Total Liabilities and Stockholders' Equity $ 124,818 $ 118,898